ArticleDrug design, development and therapy2026

Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK-Wip1 Signaling.

Jiayao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.